Mitsuyo Itabashi

Summary

Country: Japan

Publications

  1. doi request reprint Estimation of BVAS in patients with microscopic polyangiitis in Japan
    Mitsuyo Itabashi
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku, Tokyo, Japan
    Clin Rheumatol 30:1499-505. 2011
  2. doi request reprint Association between clinical characteristics and AL amyloid deposition in the kidney
    Mitsuyo Itabashi
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, 8 1 Kawadacho, Shinjuku ku, Tokyo 162 8666, Japan
    Heart Vessels 25:543-8. 2010
  3. doi request reprint Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis
    Takashi Takei
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo 162 8666, Japan
    Clin Exp Nephrol 17:92-8. 2013
  4. ncbi request reprint [Clinico-histopathological analysis of renal changes in MPO-ANCA-associated vasculitis]
    Mitsuyo Itabashi
    Department of Medicine IV, Tokyo Women s Medical University, Tokyo, Japan
    Nihon Jinzo Gakkai Shi 50:927-33. 2008
  5. doi request reprint Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function
    Takahito Moriyama
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo, 162 8666, Japan
    Clin Exp Nephrol 16:231-7. 2012
  6. doi request reprint Severity of nephrotic IgA nephropathy according to the Oxford classification
    Takahito Moriyama
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo 162 8666, Japan
    Int Urol Nephrol 44:1177-84. 2012
  7. doi request reprint Frequency of renal disease in Japan: an analysis of 2,404 renal biopsies at a single center
    Takahito Moriyama
    Department of Medicine IV, Kidney Center, Tokyo Women s Medical University, Shinjuku ku, Tokyo, Japan
    Nephron Clin Pract 115:c227-36. 2010
  8. doi request reprint Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults
    Takashi Takei
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
    Nephrol Dial Transplant 28:1225-32. 2013
  9. doi request reprint Beneficial effect of aliskiren combined with olmesartan in reducing urinary protein excretion in patients with chronic kidney disease
    Takahito Moriyama
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Kawada cho 8 1, Shinjyuku ku, Tokyo 162 8666, Japan
    Int Urol Nephrol 44:841-5. 2012
  10. doi request reprint Long-term beneficial effects of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy for patients with advanced immunoglobulin A nephropathy and impaired renal function
    Takahito Moriyama
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo 162 8666, Japan
    Clin Exp Nephrol 15:700-7. 2011

Collaborators

Detail Information

Publications42

  1. doi request reprint Estimation of BVAS in patients with microscopic polyangiitis in Japan
    Mitsuyo Itabashi
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku, Tokyo, Japan
    Clin Rheumatol 30:1499-505. 2011
    ..The initial BVAS was also predictive of the mortality and survival time and can also be used as a prognostic tool; therefore, use of the tool may facilitate the selection of appropriate treatment...
  2. doi request reprint Association between clinical characteristics and AL amyloid deposition in the kidney
    Mitsuyo Itabashi
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, 8 1 Kawadacho, Shinjuku ku, Tokyo 162 8666, Japan
    Heart Vessels 25:543-8. 2010
    ..These findings suggest that the vascular deposition pattern of amyloid in the kidney is important for determining patient survival and renal outcome...
  3. doi request reprint Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis
    Takashi Takei
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo 162 8666, Japan
    Clin Exp Nephrol 17:92-8. 2013
    ..Pathogenesis and clinical prognosis of membranoproliferative glomerulonephritis (MPGN) has not yet been established...
  4. ncbi request reprint [Clinico-histopathological analysis of renal changes in MPO-ANCA-associated vasculitis]
    Mitsuyo Itabashi
    Department of Medicine IV, Tokyo Women s Medical University, Tokyo, Japan
    Nihon Jinzo Gakkai Shi 50:927-33. 2008
    ..The pathological and clinical findings, therapies and prognoses of MPO-ANCA-associated vasculitis, were investigated in cases who showed rapidly progressive nephritic syndrome and received renal biopsy...
  5. doi request reprint Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function
    Takahito Moriyama
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo, 162 8666, Japan
    Clin Exp Nephrol 16:231-7. 2012
    ..The adaptation of steroid therapy and the effect of renin-angiotensin-aldosterone system inhibitors (RASIs) for advanced immunoglobulin A nephropathy (IgAN) patients with impaired renal function are still controversial...
  6. doi request reprint Severity of nephrotic IgA nephropathy according to the Oxford classification
    Takahito Moriyama
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo 162 8666, Japan
    Int Urol Nephrol 44:1177-84. 2012
    ..Its prognosis and response to steroid therapy are still controversial because the differential diagnosis between nephrotic IgAN and minimal change nephrotic syndrome with IgA depositions is sometimes confused...
  7. doi request reprint Frequency of renal disease in Japan: an analysis of 2,404 renal biopsies at a single center
    Takahito Moriyama
    Department of Medicine IV, Kidney Center, Tokyo Women s Medical University, Shinjuku ku, Tokyo, Japan
    Nephron Clin Pract 115:c227-36. 2010
    ..Evaluating the frequency of renal disease according to sex, age, time period and ethnicity is of considerable importance...
  8. doi request reprint Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults
    Takashi Takei
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
    Nephrol Dial Transplant 28:1225-32. 2013
    ....
  9. doi request reprint Beneficial effect of aliskiren combined with olmesartan in reducing urinary protein excretion in patients with chronic kidney disease
    Takahito Moriyama
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Kawada cho 8 1, Shinjyuku ku, Tokyo 162 8666, Japan
    Int Urol Nephrol 44:841-5. 2012
    ..Blockade of the renin-angiotensin-aldosterone system is a therapeutic mainstay in patients with chronic kidney disease (CKD). However, the renoprotective effect of the novel direct renin inhibitor aliskiren is unknown...
  10. doi request reprint Long-term beneficial effects of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy for patients with advanced immunoglobulin A nephropathy and impaired renal function
    Takahito Moriyama
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo 162 8666, Japan
    Clin Exp Nephrol 15:700-7. 2011
    ..There are few reports analyzing the effects of angiotensin-converting enzyme inhibitors (ACEIs) and/or angiotensin receptor blockers (ARBs) on the long-term renal survival of advanced immunoglobulin A nephropathy (IgAN) patients...
  11. doi request reprint Clinical outcome and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan
    Mitsuyo Itabashi
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
    Nephron Clin Pract 115:c21-7. 2010
    ..We conducted a broad survey of 99 patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis and investigated both prognosis and outcomes...
  12. ncbi request reprint A case of Mikulicz's disease complicated with severe interstitial nephritis associated with IgG4
    Asuka Aoki
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, 8 1 Kawadacho, Shinjuku ku, Tokyo 162 8666, Japan
    Clin Exp Nephrol 13:367-72. 2009
    ..The present case supports the hypothesis that IgG4-related autoimmune disease could be causes of Mikulicz's disease and interstitial nephritis...
  13. doi request reprint Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome
    Nobuyuki Amemiya
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo 162 8666, Japan
    Clin Exp Nephrol 15:933-6. 2011
    ..In 2010, we treated his sixth relapse with a single dose of rituximab. Complete remission was obtained 32 days later. This is the first report of rituximab monotherapy in the treatment of MCNS...
  14. doi request reprint Comparison of steroids and angiotensin receptor blockers for patients with advanced IgA nephropathy and impaired renal function
    Takahito Moriyama
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Japan
    Am J Nephrol 34:233-40. 2011
    ..The therapeutic strategy for advanced IgA nephropathy patients with impaired renal function is still controversial...
  15. ncbi request reprint Rituximab treatment for adult patients with focal segmental glomerulosclerosis
    Ayami Ochi
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Japan
    Intern Med 51:759-62. 2012
    ..Rituximab may be an effective treatment agent for SDNS with FSGS and the peripheral B-cell count may be a useful marker in such patients for preventing disease relapse...
  16. ncbi request reprint Antiphospholipid antibodies and renal outcomes in patients with lupus nephritis
    Yuki Tsuruta
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
    Intern Med 48:1875-80. 2009
    ..The aims of this study were to evaluate the seroprevalence of aPL antibodies in patients with lupus nephritis and assess their prognostic value in relation to long-term renal outcomes...
  17. doi request reprint Effect of single-dose rituximab on primary glomerular diseases
    Hidekazu Sugiura
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
    Nephron Clin Pract 117:c98-105. 2011
    ..Rituximab, which acts by inhibiting CD20-mediated B cell proliferation and differentiation, could be effective in the treatment of nephrotic syndrome as shown in recent reports...
  18. ncbi request reprint Effects of combination therapy with renin-angiotensin system inhibitors and eicosapentaenoic acid on IgA nephropathy
    Takahito Moriyama
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Japan
    Intern Med 52:193-9. 2013
    ..However, it is unknown whether these agents have any synergistic interactions...
  19. ncbi request reprint Successful use of single-dose rituximab for the maintenance of remission in a patient with steroid-resistant nephrotic syndrome
    Noritomo Kurosu
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
    Intern Med 48:1901-4. 2009
    ..We conclude that rituximab may be an effective treatment agent for resistant nephrotic syndrome and the peripheral B cell count may be a useful marker in such patients for preventing disease relapse...
  20. ncbi request reprint [Case of MMF monotherapy for membranous nephropathy]
    Mioko Kobayashi
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
    Nihon Jinzo Gakkai Shi 52:572-7. 2010
    ..No digestive symptoms, kidney function worsening or increase in blood pressure were noted during treatment. These findings suggest that MMF monotherapy is effective and safe for the treatment of membranous nephropathy...
  21. doi request reprint Effect of kidney disease stage on pregnancy and delivery outcomes among patients with immunoglobulin A nephropathy
    Ari Shimizu
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
    Am J Nephrol 32:456-61. 2010
    ..The effects and outcome of pregnancy in women with renal diseases remain controversial, and the characteristics and outcome of pregnancy in IgAN patients must be further evaluated...
  22. doi request reprint The significance of caveolae in the glomeruli in glomerular disease
    Takahito Moriyama
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
    J Clin Pathol 64:504-9. 2011
    ..The aim of this study was to demonstrate expression of cell membrane invagination 'caveolae' in glomeruli and to correlate this with functional and structural characteristics of the human glomerular diseases...
  23. pmc Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan
    Takahito Moriyama
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
    PLoS ONE 9:e91756. 2014
    ..Little is known about the long-term prognosis of patients with IgA nephropathy (IgAN)...
  24. ncbi request reprint A case of AL amyloidosis with renal rupture
    Yuko Iwabuchi
    Department of Medicine, Kidney Center, Tokyo Women s Medical University
    Intern Med 49:2129-32. 2010
    ..Histopathological examination revealed a greater degree of amyloid deposition in the resected kidney than that at the time of diagnosis. Amyloid angiopathy may promote bleeding...
  25. doi request reprint Two cases of ANCA-associated vasculitis in post-transplant kidney: relapse and de novo
    Hidehiro Tabata
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
    Clin Transplant 23:49-53. 2009
    ....
  26. ncbi request reprint [Successful rituximab therapy for MALT lymphoma complicating cryoglobulinemic glomerulonephritis]
    Kenichi Akiyama
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
    Nihon Jinzo Gakkai Shi 53:713-8. 2011
    ..Her proteinuria disappeared and renal function improved after rituximab therapy. In our case, nephrotic syndrome due to cryoglobulinemic glomerulonephritis was successfully treated mainly by rituximab...
  27. ncbi request reprint Ruptured arterial aneurysm of the kidney in a patient with microscopic polyangiitis
    Noriko Tamei
    Department of Medicine, Kidney Center, Tokyo Women s Medical University
    Intern Med 47:521-6. 2008
    ..Multiple aneurysms detected by angiography in the renal and hepatic arteries showed improvement. He is currently stable on regular hemodialysis treatment with a low dose of oral prednisolone...
  28. ncbi request reprint Risedronate therapy for the prevention of steroid-induced osteoporosis in patients with minimal-change nephrotic syndrome
    Takashi Takei
    Department of Medicine, Kidney Center, Tokyo Women s Medical University
    Intern Med 49:2065-70. 2010
    ..Minimal-change nephrotic syndrome (MCNS) is treated by the administration of prednisolone (PSL) at high doses. Steroid-induced osteoporosis is a serious adverse effect of this drug...
  29. doi request reprint Statins stabilize the renal function of IgA nephropathy
    Takahito Moriyama
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
    Ren Fail 36:356-60. 2014
    ..The renoprotective pleiotropic effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) has recently been reported by several investigators. However, the effect of statins on IgA nephropathy (IgAN) is still unknown...
  30. doi request reprint Long-term damage assessment in patients with microscopic polyangiitis and renal-limited vasculitis using the Vasculitis Damage Index
    Mitsuyo Itabashi
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo 162 8666, Japan
    Mod Rheumatol 24:112-9. 2014
    ..We conducted a retrospective study of 30 patients with microscopic polyangiitis (MPA) and renal-limited vasculitis (RLV)...
  31. ncbi request reprint The characteristics of relapse in adult-onset minimal-change nephrotic syndrome
    Takashi Takei
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, 8 1 Kawadacho, Shinjuku ku, Tokyo 162 8666, Japan
    Clin Exp Nephrol 11:214-7. 2007
    ..It is, therefore, necessary to identify factors that can predict this increased risk of relapse in some patients in order to establish useful treatment methods to reduce the risk...
  32. ncbi request reprint A novel mouse model for MPO-ANCA-associated glomerulonephritis
    Wako Yumura
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Japan
    Microbiol Immunol 50:149-57. 2006
    ..These findings indicate that BSA induces neutrophil activation of peripheral blood followed by the elevation of MPO-ANCA, resulting in the development of crescentic glomerulonephritis in mice...
  33. ncbi request reprint Serum cystatin C concentration as a marker of glomerular filtration rate in patients with various renal diseases
    Kosaku Nitta
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Tokyo
    Intern Med 41:931-5. 2002
    ..The present study was undertaken to evaluate clinical application of serum cystatin C as a new marker of glomerular filtration rate (GFR) in patients with various renal diseases...
  34. ncbi request reprint Pharmacokinetics of orally administered tacrolimus in lupus nephritis patients
    Keiko Uchida
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
    Yakugaku Zasshi 130:113-8. 2010
    ..We recommend that monitoring should be carried out by C(12 h) in lupus nephritis outpatients...
  35. ncbi request reprint [Clinico-pathological features and outcome in adult patients with Henoch-Schönlein purpura nephritis]
    Yuki Tsuruta
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
    Nihon Jinzo Gakkai Shi 52:51-7. 2010
    ..It may be necessary to consider the decrease in nephrons, in accordance with non-immunological glomerular obsolescence, in addition to immunological treatment to clarify the prognosis...
  36. ncbi request reprint Clinical and pathological studies of IgA nephropathy presenting as a rapidly progressive form of glomerulonephritis
    Ari Shimizu
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Japan
    Intern Med 52:2489-94. 2013
    ..IgA nephropathy (IgAN) is widely regarded as a slowly progressive disease. However, a minor population of patients present with a rapidly progressive form of glomerulonephritis (RPGN)...
  37. doi request reprint A case of acute renal failure after exercise with renal hypouricemia demonstrated compound heterozygous mutations of uric acid transporter 1
    Ayami Ochi
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo, 162 8666, Japan
    Clin Exp Nephrol 16:316-9. 2012
    ..Thus, we describe a Japanese male with hypouricemia complicated by anerobic exercise-induced ARF, with definite demonstration of a genetic abnormality in the responsible gene, URAT1...
  38. doi request reprint A case report of uncompensated alkalosis induced by daily plasmapheresis in a patient with thrombotic thrombocytopenic purpura
    Yoshiko Nagai
    Department of Medicine IV, Tokyo Women s Medical University, Tokyo, Japan
    Ther Apher Dial 12:86-90. 2008
    ..Metabolic alkalosis is a common complication in TTP patients treated by frequent PP, but several factors that affect metabolic status may aggravate the alkalosis and induce uncompensated alkalosis...
  39. ncbi request reprint [A case of microscopic polyangitis with sepsis due to pyelonephritis]
    Chiari Kojima
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
    Nihon Jinzo Gakkai Shi 47:876-81. 2005
    ..These findings suggest immunoglobulin therapy to be a safe immuno-suppressive treatment that is efficacious against ANCA-associated glomerulonephritis...
  40. ncbi request reprint [Effects of steroid therapy on membranous nephropathy]
    Takashi Takei
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
    Nihon Jinzo Gakkai Shi 50:597-601. 2008
    ..Although membranous nephropathy is a common cause of nephrotic syndrome in adults, its treatment remains under debate...
  41. ncbi request reprint Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients
    Kazuho Honda
    Department of Pathology, Tokyo Women s Medical University, Tokyo, Japan
    Adv Perit Dial 19:169-75. 2003
    ..Careful histologic observation of the peritoneal biopsy after withdrawal of peritoneal dialysis is required for the early diagnosis and prevention of EPS...
  42. ncbi request reprint [Low-dose cyclosporin therapy combined with prednisolone for relapsing minimal change nephrotic syndrome in adults]
    Minako Koike
    Department of Medicine, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
    Nihon Jinzo Gakkai Shi 44:447-52. 2002
    ..7 +/- 24.3%-->88.6 +/- 14.5%, p = 0.01). Thus, the low dose cyclosporin(CsA) therapy combined with prednisolone was an effective treatment for adult MCNS patients who relapsed frequently under conventional prednisolone therapy...